Literature DB >> 22714623

Diagnosis of longitudinally extensive transverse myelitis.

Helen Nightingale1, Jonathan Witherick, Alastair Wilkins.   

Abstract

Longitudinally extensive transverse myelitis (LETM) is a neurological condition characterised by a contiguous inflammatory lesion of the spinal cord. LETM is often associated with the autoimmune central nervous system disease neuromyelitis optica (NMO) and rarely with multiple sclerosis. The discovery of the NMO-IgG antibody, provides a useful serological marker of LETM associated with the NMO disease spectrum (LETM and/or optic neuritis). Here, the authors report two cases of LETM, which differ in disease severity and NMO-IgG antibody serological status.

Entities:  

Mesh:

Year:  2011        PMID: 22714623      PMCID: PMC3062359          DOI: 10.1136/bcr.10.2010.3444

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

Review 1.  Neuromyelitis optica.

Authors:  J M S Pearce
Journal:  Spinal Cord       Date:  2005-11       Impact factor: 2.772

Review 2.  Neuromyelitis optica: a distinct demyelinating disease of the central nervous system.

Authors:  A A Argyriou; N Makris
Journal:  Acta Neurol Scand       Date:  2008-03-11       Impact factor: 3.209

Review 3.  Neuromyelitis optica: an overview.

Authors:  R Nandhagopal; Abdullah Al-Asmi; Arunodaya R Gujjar
Journal:  Postgrad Med J       Date:  2010-03       Impact factor: 2.401

4.  Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.

Authors:  Brian G Weinshenker; Dean M Wingerchuk; Sandra Vukusic; Linda Linbo; Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

5.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

Review 6.  Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.

Authors:  Philippe Saikali; Romain Cayrol; Thierry Vincent
Journal:  Autoimmun Rev       Date:  2009-04-21       Impact factor: 9.754

Review 7.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

8.  Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.

Authors:  Elisa Bizzoco; Francesco Lolli; Anna Maria Repice; Bahia Hakiki; Mario Falcini; Alessandro Barilaro; Rosanna Taiuti; Gianfranco Siracusa; Maria Pia Amato; Tiziana Biagioli; Silvia Lori; Marco Moretti; Annalisa Vinattieri; Patrizia Nencini; Luca Massacesi; Sabrina Matà
Journal:  J Neurol       Date:  2009-05-28       Impact factor: 4.849

Review 9.  Transverse myelitis spectrum disorders.

Authors:  Lekha Pandit
Journal:  Neurol India       Date:  2009 Mar-Apr       Impact factor: 2.117

10.  Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.

Authors:  J C J Bot; F Barkhof; C H Polman; G J Lycklama à Nijeholt; V de Groot; E Bergers; H J Ader; J A Castelijns
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

  10 in total
  3 in total

1.  Myelitis Following COVID-19 Illness.

Authors:  Nihal Gulati; Saniya Kapila; Lucky Bhalla Sehgal; Vineet Sehgal; Priyal Lnu
Journal:  Cureus       Date:  2022-08-18

2.  Longitudinally extensive transverse myelitis with intramedullary metastasis of small-cell lung carcinoma: an autopsy case report.

Authors:  Kenya Nishioka; Ryota Tanaka; Satoshi Tsutsumi; Hideki Shimura; Yutaka Oji; Harumi Saeki; Yukimasa Yasumoto; Masanori Ito; Nobutaka Hattori; Takao Urabe
Journal:  Case Rep Neurol Med       Date:  2013-12-22

3.  Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2.

Authors:  Christoph Helmchen; Gesine M Buttler; Robert Markewitz; Katja Hummel; Heinz Wiendl; Tobias Boppel
Journal:  J Neurol       Date:  2021-06-15       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.